QQ客服 官方微博 反馈留言

	21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.
	Zhang, Wen-Wen; Tong, Qin; Sun, Jia-Yuan; Hua, Xin; Long, Zhi-Qing; Deng, Jia-Peng; Dong, Yong; Li, Fang-Yan; He, Zhen-Yu; Wu, San-Gang*
刊名	Frontiers in oncology
	2019
卷号	9期号:MAR页码:270
关键词	21-gene recurrence score (RS) assay and end results (SEER) database breast cancer epidemiology micrometastasis of lymph nodes post-mastectomy radiotherapy (PMRT) surveillance
ISSN号	2234-943X
DOI	10.3389/fonc.2019.00270
URL标识	查看原文
WOS记录号	WOS:000464935300001
内容类型	期刊论文
URI标识	http://www.corc.org.cn/handle/1471x/5691623
专题	南华大学
作者单位	1.[Li, Fang-Yan 2.Lin, Huan-Xin 3.Sun, Jia-Yuan 4.Hua, Xin 5.Zhang, Wen-Wen 6.Deng, Jia-Peng 7.Long, Zhi-Qing 8.He, Zhen-Yu] Sun Yat Sen Univ, Canc Ctr, State Key Lab Oncol Southern China, Dept Radiat Oncol,Collaborat Innovat Ctr Canc Med, Guangzhou, Guangdong, Peoples R China.
推荐引用方式 GB/T 7714	Zhang, Wen-Wen,Tong, Qin,Sun, Jia-Yuan,et al. 21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.[J]. Frontiers in oncology,2019,9(MAR):270.
APA	Zhang, Wen-Wen.,Tong, Qin.,Sun, Jia-Yuan.,Hua, Xin.,Long, Zhi-Qing.,...&Lin, Huan-Xin*.(2019).21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer..Frontiers in oncology,9(MAR),270.
MLA	Zhang, Wen-Wen,et al."21-Gene Recurrence Score Assay Could Not Predict Benefit of Post-mastectomy Radiotherapy in T1-2 N1mic ER-Positive HER2-Negative Breast Cancer.".Frontiers in oncology 9.MAR(2019):270.

个性服务

查看访问统计

相关权益政策

暂无数据

收藏/分享

除非特别说明，本系统中所有内容都受版权保护，并保留所有权利。